{
    "2018-09-06": [
        [
            {
                "time": "2023-10-05",
                "original_text": "MS Global Franchise Fund Buys 1, Sells 4 in 2nd Quarter",
                "features": {
                    "keywords": [
                        "MS Global Franchise Fund",
                        "Buys",
                        "Sells",
                        "2nd Quarter"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "7 Lucrative Biotech Stocks With Up to 300% Upside",
                "features": {
                    "keywords": [
                        "Lucrative",
                        "Biotech Stocks",
                        "300% Upside"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "What Alexion Pharmaceuticalsâ€™ Valuation Trend Indicates",
                "features": {
                    "keywords": [
                        "Alexion Pharmaceuticals",
                        "Valuation Trend"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Livongo Health expands under new offering with Abbott Labs",
                "features": {
                    "keywords": [
                        "Livongo Health",
                        "expands",
                        "new offering",
                        "Abbott Labs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}